Geetha Subramaniam

Learn More
OBJECTIVE To evaluate the efficacy and safety of osmotic-release methylphenidate (OROS-MPH) compared with placebo for attention-deficit/hyperactivity disorder (ADHD), and the impact on substance treatment outcomes in adolescents concurrently receiving cognitive-behavioral therapy (CBT) for substance use disorders (SUD). METHOD This was a 16-week,(More)
Co-occurring major depressive disorder (MDD) in adolescents with substance use disorders (SUD) has been linked to poor treatment outcomes. Use of validated depression screens in adolescent SUD populations may improve the detection of depression. In this study, we evaluated the diagnostic efficiency of the Beck Depression Inventory (BDI) in detecting MDD, as(More)
OBJECTIVE Cannabis use is common among opioid-dependent patients, but studies of its association with treatment outcome are mixed. In this secondary analysis, the association of cannabis use with opioid treatment outcome is assessed. METHODS In the main study, participants (n=152) aged 15-21 years were randomized to receive psychosocial treatments and(More)
Clinical Questions: 1. What is the research evidence for the treatment of opioid-dependent youth with buprenorphine? 2. What special issues should be considered when treating adolescents with buprenorphine? Background: While the use of heroin has remained low and stable (at approximately 1%), the use of non-heroin opioids, the second most commonly used(More)
  • 1